Search

Your search keyword '"Center for Applied Medical Research [Plamplona] (CIMA)"' showing total 44 results

Search Constraints

Start Over You searched for: Author "Center for Applied Medical Research [Plamplona] (CIMA)" Remove constraint Author: "Center for Applied Medical Research [Plamplona] (CIMA)"
44 results on '"Center for Applied Medical Research [Plamplona] (CIMA)"'

Search Results

1. Comparing algorithms for automated vessel segmentation in computed tomography scans of the lung: The VESSEL12 study

2. A machine learning derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial

3. Contribution of IL-17-producing {gamma}{delta} T cells to the efficacy of anticancer chemotherapy

4. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure

5. Spatio-temporal soil drying in southeastern South America: the importance of effective sampling frequency and observational errors on drydown time scale estimates

6. Benefits of representing floodplains in a Land Surface Model: Pantanal simulated with ORCHIDEE CMIP6 version

7. Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology

8. Design and validation of a tunable inertial microfluidic system for the efficient enrichment of circulating tumor cells in blood

9. Prevalence and polymorphism of a mussel transmissible cancer in Europe

10. Bringing onco?innovation to Europe’s healthcare systems: The potential of biomarker testing, real world evidence, tumour agnostic therapies to empower personalised medicine

11. Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial

12. The hCOMET project: International database comparison of results with the comet assay in human biomonitoring. Baseline frequency of DNA damage and effect of main confounders

13. COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology

14. Combinatorial Nanomedicine Made of Squalenoyl-Gemcitabine and Edelfosine for the Treatment of Osteosarcoma

15. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint

16. A Role for MMP-10 (Matrix Metalloproteinase-10) in Calcific Aortic Valve Stenosis

17. Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility

18. The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma: sVEGFR1, lung tumor progression and anti-angiogenics

19. Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update

20. Sparse force-bearing bridges between neighboring synaptic vesicles

21. Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure

22. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process

23. Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trials

24. Preclinical Evaluation of a Cell-Based Gene Therapy Using the Sleeping Beauty Transposon System in Choroidal Neovascularization

25. Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology

26. Heart failure and diabetes

27. Loss of miR-198 and -206 during primary tumor progression enables metastatic dissemination in human osteosarcoma

28. The sVEGFR1-i13 splice variant regulates a β1 integrin/VEGFR autocrine loop involved in the progression and the response to anti-angiogenic therapies of squamous cell lung carcinoma

29. Predictors of responses to immune checkpoint blockade in advanced melanoma

30. Long-Term PEDF Release in Rat Iris and Retinal Epithelial Cells after Sleeping Beauty Transposon-Mediated Gene Delivery

31. ΔNp63α Silences a miRNA Program to Aberrantly Initiate a Wound-Healing Program That Promotes TGFβ-Induced Metastasis

32. Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential

33. NMDA receptor GluN2A/GluN2B subunit ratio as synaptic trait of levodopa-induced dyskinesias: from experimental models to patients

34. Whole-genome fingerprint of the DNA methylome during human B cell differentiation

35. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization

36. Modeling tumor response after combined administration of different immune-stimulatory agents

37. Node accessibility in cortical networks during motor tasks

38. Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration

39. Mathematical Model Approach to Describe Tumour Response in Mice After Vaccine Administration and its Applicability to Immune-Stimulatory Cytokine-Based Strategies

40. Community structure in large-scale cortical networks during motor acts

41. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma

42. Priorities in Parkinson's disease research

43. Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders

44. A global benchmark study using affinity-based biosensors

Catalog

Books, media, physical & digital resources